相关阅读

Array ( [0] => Array ( [relateid] => 794320 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/794320.html [wapUrl] => https://m.jnnc.com/p/794320.html [published_timestamp] => 1584425457 [published] => 1584425457 [pv] => 540 [virtual_pv] => 0 [all_pv] => 540 [title] => 美国新冠病毒疫苗开始第一阶段临床试验 [has_thumb] => 0 [thumb] => ) [1] => Array ( [relateid] => 794498 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/794498.html [wapUrl] => https://m.jnnc.com/p/794498.html [published_timestamp] => 1584576917 [published] => 1584576917 [pv] => 199 [virtual_pv] => 0 [all_pv] => 199 [title] => 钟南山：不能靠集体免疫，疫苗是解决新冠肺炎的根本 [has_thumb] => 0 [thumb] => ) [2] => Array ( [relateid] => 794369 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/794369.html [wapUrl] => https://m.jnnc.com/p/794369.html [published_timestamp] => 1584490006 [published] => 1584490006 [pv] => 194 [virtual_pv] => 0 [all_pv] => 194 [title] => 药物、疫苗研发有何新进展？中医药抗“疫”效果怎样？ [has_thumb] => 0 [thumb] => ) [3] => Array ( [relateid] => 793857 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/793857.html [wapUrl] => https://m.jnnc.com/p/793857.html [published_timestamp] => 1583891914 [published] => 1583891914 [pv] => 236 [virtual_pv] => 0 [all_pv] => 236 [title] => 韩国称合成出可识别新冠病毒抗体的蛋白质 [has_thumb] => 0 [thumb] => ) [4] => Array ( [relateid] => 794914 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/794914.html [wapUrl] => https://m.jnnc.com/p/794914.html [published_timestamp] => 1585009242 [published] => 1585009242 [pv] => 229 [virtual_pv] => 0 [all_pv] => 229 [title] => 联合国特别报告员：使用别有用心的名称来替代新冠病毒不负责任 [has_thumb] => 0 [thumb] => ) )
• 美国新冠病毒疫苗开始第一阶段临床试验
• 钟南山：不能靠集体免疫，疫苗是解决新冠肺炎的根本
• 药物、疫苗研发有何新进展？中医药抗“疫”效果怎样？
• 韩国称合成出可识别新冠病毒抗体的蛋白质
• 联合国特别报告员：使用别有用心的名称来替代新冠病毒不负责任